Source: Annual Congress 2002 - Asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. L. Shaporova, V. I. Trofimov, Z. A. Shiri, T. P. Ses, L. V. Stelmakh (Saint-Petersburg, Russia). Immunological mechanisms of intravenous roncoleucin (IL-2) clinical effects in asthmatic patients. Eur Respir J 2002; 20: Suppl. 38, 3197

Member's Comments

No comment yet.

Related content which might interest you: IL-2 intravenous application as one of the new ways of immunomodulative therapy of the asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 589s Year: 2002 Cytokines concentrations in induced sputum of mild COPD patients. Correlation to clinical response to inhaled corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 309s Year: 2002 Relationship between omalizumab pharmacokinetics (PK), IgE pharmacodynamics (PD) and clinical symptoms in patients with severe persistent allergic asthma Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008 Late Breaking Abstract - The biological pathways underlying response to anti-IL-17A (AIN457; secukinumab) therapy differ across severe asthmatic patients. Source: International Congress 2017 – Update and new perspectives in Airway Diseases Year: 2017 Immunomodulatory treatment of severe persistent asthma with interferon-αcon-1 (IFN-αcon-1). Effect on the clinical course of oral corticosteroid dose and eosinophil numbers Source: Annual Congress 2003 - Modulation of bronchial hyperreactivity and immune response in the airways Year: 2003 Cytokine production profile of T-lymphocytes and frequence of regulatory T-cells in patients with allergic asthma receiving anti-IgE therapy Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011 Effects of dexamethasone and anti-inflammatory drugs on inflammatory cytokines from bronchial epithelial cells of COPD patients Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Antiviral biomarkers are upregulated in sputum cells following administration of inhaled interferon beta to COPD patients Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 Anti-inflammatory effect of montelukast (ML) and inhaled steroids (ICS) on clinical parameters and serum levels of NO in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 132s Year: 2003 Blood eosinophil dose response to oral corticosteroids in a population of patients with severe asthma Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Immunogenicity assessment of intravenous administration of reslizumab in patients with asthma in phase 3 clinical studies Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Effect of inhaled SNG001 (interferon-beta 1a) on sputum and blood antiviral biomarkers following a respiratory virus infection in asthmatic subjects Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 The effect of statin usage on airway inflammatiory cells and markers, and clinical indices in asthmatic patients Source: Annual Congress 2011 - Asthma management and response Year: 2011 The assesment of serum TNFα levels in COPD acute exacerbation and the effects of inhaler steroids on clinical and inflammatory determinants Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002 The effects of oral corticosteroid treatment (OCS) on sequential lung function tests in a cohort of patients with acute hypersensitivity pneumonitis (AHP) Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 Effects of low dose inhaled theophylline (ADC4022) co-administered with budesonide on inflammatory markers, lung function, and quality of life in COPD patients Source: Annual Congress 2009 - New drugs for airways disease Year: 2009 Comparison of the effectiveness of azithromycin and budesonide versus theophylline and budesonide in the suppression of pro-inflammatory cytokines in patients with COPD Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2020 Expression of inflammatory cytokines following stepwise dose reduction of corticosteroids of long-term oral corticosteroids users with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 62s Year: 2004 Monitoring of inflammatory changes in patients with bronchial asthma before and after oral corticosteroid treatment Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008